Views & Analysis Collaborate to simplify cancer trials and accelerate post-pa... How could simplifying the administration of clinical trials help cancer diagnosis, care, and treatment levels to exceed pre-pandemic levels?
Views & Analysis NICE feedback? The National Institute for Health and Care Excellence (NICE) is quite far along a NICE-led process to
Digital How digital pathways are changing healthcare As demonstrated throughout COVID, digital health is no longer experimental.
Views & Analysis A life sciences vision to deliver health, wealth and resilie... The ABPI’s chief executive Dr Richard Torbett outlines a new ‘vision’ and
Views & Analysis Deep Dive: Oncology 2021 This has probably been the toughest year for oncology researchers in memory.
Views & Analysis Building honest dialogue with patient advocates How can the industry listen to patients in a way that puts the person behind the disease first?
Digital Chaos & opportunity: Dr Adam Brown unpacks US health policy Dive into our video interview with Dr Adam Brown as he unpacks the chaos and opportunity shaping US health policy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face